Nautilus Biotechnology, Inc.

NASDAQ:NAUT

2.87 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -63.675-57.924-50.315-15.619-9.618626.6
Depreciation & Amortization 5.7053.4162.8422.3460.5480
Deferred Income Tax -0.3930000.7740
Stock Based Compensation 12.13710.387.9340.3690.110
Change In Working Capital -3.219-0.788-0.022-1.387-0.5451.327
Accounts Receivables 000000
Inventory 000000
Accounts Payables 0.393-0.5611.2610.1230.1070
Other Working Capital -0.393-0.227-1.283-1.51-0.5450
Other Non Cash Items -2.266-0.890.320.295-0.157-866.225
Operating Cash Flow -51.711-45.806-39.241-13.996-9.662-238.298
Investing Activities:
Investments In Property Plant And Equipment -2.442-2.324-2.269-0.921-0.9260
Acquisitions Net -71.599-163.1750.1370.02400
Purchases Of Investments -112.892-186.591-221.795-68.35900
Sales Maturities Of Investments 71.599163.17585.144.00100
Other Investing Activites 71.599163.175-0.137-0.0244.9761.198
Investing Cash Flow -43.735-25.74-138.964-25.2794.051.198
Financing Activities:
Debt Repayment 000000
Common Stock Issued 0.3680.562-7.96275.89900
Common Stock Repurchased 0.2640.23200-0.874-1.198
Dividends Paid 000000
Other Financing Activities 0.3680.562327.44775.8990.036145,187.802
Financing Cash Flow 0.3680.562327.44775.8990.036145,186.604
Other Information:
Effect Of Forex Changes On Cash 00000.006-144,948.306
Net Change In Cash -95.078-70.984149.24236.624-1,197.7111.198
Cash At End Of Period 20.399115.477186.46137.2190.5951.198